1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc.

DNTH
Dianthus Therapeutics, Inc.US flagNASDAQ
104.94
USD
-0.78
- -
4.38BMarket Cap

Income Statement (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
1
6
3
6
2
+ Sales & Services Revenue
1
6
3
6
2
- Cost of Revenue
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
+ Other Operating Income
-1
-6
-3
-6
-2
- Operating Expenses
15
36
51
108
180
+ Selling, General & Admin
2
7
18
25
34
+ Research & Development
13
29
33
83
146
+ Other Operating Expense
- -
- -
- -
- -
- -
Operating Income (Loss)
-13
-30
-48
-102
-178
- Non-Operating (Income) Loss
- -
-1
-5
-17
-16
+ Interest Expense, Net
- -
-1
-5
-17
-16
+ Interest Expense
- -
- -
- -
- -
- -
- Interest Income
- -
1
5
17
16
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
1
Pretax Income
-13
-28
-44
-85
-162
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-13
-28
-44
-85
-162
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-13
-28
-44
-85
-162
- Minority Interest
- -
- -
- -
- -
- -
Net Income, GAAP
-13
-28
-44
-85
-162
- Preferred Dividends
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-13
-28
-44
-85
-162
EBIT
-13
-30
-48
-102
-178
EBITDA
-13
-30
-48
-101
-178
EBITDA Margin (%)
-886.59
-460.62
-1,692.11
-1,627.14
-8,718.32
EBITA
-13
-30
-48
-102
-178
Gross Margin (%)
100
100
100
100
100
Operating Margin (%)
-886.59
-462.91
-1,704.67
-1,633.74
-8,739.34
Profit Margin (%)
-888.14
-443.76
-1,541.22
-1,362.77
-7,973.33
Sales per Employee
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
15
15
5
33
39
Basic EPS, GAAP
-0.88
-1.92
-8.45
-2.55
-4.2
Basic EPS from Cont Ops
-0.88
-1.92
-8.45
-2.55
-4.2
Diluted Weighted Avg Shares
15
15
5
33
39
Diluted EPS, GAAP
-0.88
-1.92
-8.45
-2.55
-4.2
Diluted EPS from Cont Ops
-0.88
-1.92
-8.45
-2.55
-4.2

Balance Sheet (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
9
82
177
281
409
+ Cash, Cash Equivalents & STI
8
75
174
275
404
+ Cash & Cash Equivalents
8
15
132
23
51
+ ST Investments
- -
60
41
252
353
+ Accounts & Notes Receiv
1
6
- -
1
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
+ Other Receivable, Net
1
6
- -
1
- -
+ Inventories
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
3
5
5
+ Misc ST Assets
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
1
2
93
121
+ Property, Plant & Equip, Net
- -
1
1
2
2
+ Property, Plant & Equip
- -
1
1
2
2
- Accumulated Depreciation
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
82
110
+ LT Investments
- -
- -
- -
82
110
+ LT Receivables
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
1
10
10
+ Total Intangible Assets
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
1
10
10
Total Assets
9
83
179
374
531
+ Payables & Accruals
5
6
4
12
20
+ Accounts Payable
1
1
3
5
10
+ Accrued Taxes
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
+ Other Payables & Accruals
4
5
1
8
10
+ ST Debt
- -
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
2
5
6
11
+ Deferred Revenue
- -
- -
- -
- -
1
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
2
5
5
10
Total Current Liabilities
5
8
10
18
31
+ LT Debt
- -
- -
- -
1
1
+ LT Borrowings
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
1
1
+ Other LT Liabilities
21
1
1
2
6
+ Accrued Liabilities
- -
1
1
2
6
+ Pension Liabilities
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Misc LT Liabilities
21
- -
- -
- -
- -
Total Noncurrent Liabilities
21
1
1
3
7
Total Liabilities
27
9
11
22
38
+ Preferred Equity and Hybrid Capital
- -
118
- -
- -
- -
+ Share Capital & APIC
- -
2
258
527
830
+ Common Stock
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
2
258
527
830
- Treasury Stock
- -
- -
- -
- -
- -
+ Retained Earnings
-17
-46
-89
-174
-337
+ Other Equity
- -
- -
- -
- -
- -
Equity Before Minority Interest
-17
74
169
352
493
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
Total Equity
-17
74
169
352
493
Total Liabilities & Equity
9
83
179
374
531
Shares Outstanding
15
15
15
31
43
Number of Employees
- -
- -
- -
- -
- -
Capital Leases - Total
- -
1
1
1
1
Net Debt
-8
-15
-132
-23
-51
Net Debt to Equity
44.28
-20.86
-78.36
-6.47
-10.35
Tangible Common Equity Ratio
-182.51
-53.38
94.13
94.24
92.93
Current Ratio
1.75
9.97
18.42
15.22
13.32
Cash Conversion Cycle
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-13
-28
-44
-85
-162
+ Depreciation & Amortization
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
1
1
7
16
+ Stock-Based Compensation
- -
2
3
13
23
+ Deferred Income Taxes
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
-1
-1
-6
-7
+ Chg in Non-Cash Work Cap
3
-2
5
- -
17
+ (Inc) Dec in Accts Receiv
-1
-4
5
- -
1
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
- -
-2
- -
+ Inc (Dec) in Accts Payable
5
2
1
8
11
+ Inc (Dec) in Other
- -
1
-1
-7
5
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Operating Activities
-10
-29
-37
-78
-129
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
72
269
272
+ Increase in Capital Stock
- -
- -
72
269
272
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
-60
20
-287
-123
+ Dec in LT Investment
- -
2
78
127
312
+ Inc in LT Investment
- -
-62
-57
-414
-435
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
-60
20
-287
-123
+ Dividends Paid
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
+ Other Financing Activities
15
97
62
-14
8
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Financing Activities
15
97
134
256
280
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
Net Changes in Cash
5
8
117
-109
28
EBITDA
-13
-30
-48
-101
-178
EBITDA Margin (%)
-886.59
-460.62
-1,692.11
-1,627.14
-8,718.32
Free Cash Flow
-10
-29
-37
-78
-129
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
89
-155
-78
-129
Free Cash Flow per Basic Share
-0.67
-1.96
-7.15
-2.35
-3.34
Price/Free Cash Flow
-106.05
-3.22
-1.45
-9.29
-12.33
Cash Flow to Net Income
0.76
1.02
0.85
0.92
0.8
Capital Expenditures
- -
- -
- -
- -
- -